Christopher G R Perry is an expert in Biochemistry at York University (Canada). Christopher G R Perry has authored 124 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 420 (community average: 125). How the SLR is computed.

LeadR Profile

Christopher G R Perry York University Canada
420 ScienceLeadR Reputation 420
Network Map

Biochemistry

Subspecialties: Nutrition - Endocrinology - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2005 - 2026

Source: PubMed

York University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 124

Citations

Citations: 3 274 1st author: 14 Last author: 38 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Effects of cytoplasmic free Mg 2+ buffering on skeletal muscle fatigue in intact single mouse muscle fibers.
PMID 42809442 — sarcoplasmic reticulum, muscles, buffers, muscle fatigue, fatigue, muscle, skeletal, muscle fibers, skeletal, ryanodine receptor calcium release channel
Am J Physiol Cell Physiol20260
Post-exercise consumption of milk or Greek yogurt may support the anti-inflammatory environment following high-intensity exercise.
PMID 42719265 — cytokines, exercise, milk, dairy products, yogurt, environment
Front Sports Act Living20260
High-intensity interval training via electrical stimulation enhances endurance by preserving sarcoplasmic reticulum Ca 2+ transients in mouse skeletal muscle.
PMID 42691477 — cell physiological phenomena, sarcoplasmic reticulum, muscles, fatigue, calcium, muscle, skeletal, high-intensity interval training
Am J Physiol Cell Physiol20260
Differential Branched-Chain Amino Acid Metabolism in Tissues of Tumor-Bearing Male Mice.
PMID 42126062 — muscles, amino acids, neoplasms, liver, leucine, therapeutics, muscle, skeletal, tissues, mechanistic target of rapamycin complex 1, amino acids, branched-chain, cachexia, adipose tissue, cancer-associated cachexia
Am J Physiol Regul Integr Comp Physiol20260
The mitochondrial-targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial-apoptotic but not necroptotic signalling during ovarian cancer.
PMID 41177963 — muscular atrophy, cells, physiology, muscles, atrophy, necroptosis, neoplasms, mitochondria, caspases, antioxidants, ovarian neoplasms, muscle, skeletal, apoptosis, caspase 9, cell death, cachexia
J Physiol20250

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2

By status:

Completed 1
Recruiting 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Healthy Outcomes for Muscle with Exercise in T1D
NCT05740514 — diabetes mellitus, exercise, quality of life, muscles, insulin, incidence, muscle, skeletal, diabetes mellitus, type 1, female, male
N/ARecruiting2023

LeadR Networks

Main global connection map